Benitec's own programs

Benitec Biopharma’s in-house programs target chronic and life-threatening conditions which are gene-associated, and for which there is no effective treatment or cure.

Our in-house pipeline, based on our proprietary ddRNAi gene-silencing technology, is summarized below, with links to individual program details. Successful development of therapeutic products in just one of these programs would be a major breakthrough in medical therapy.

View details and status of each in-house program via these links:

See details of the programs out-licensed to other biotechnology and biopharma companies here.